Speakers
Session 1: Keynote Discussion – Navigating the Frontiers of Innovation and Value
Mark McClellan | Duke-Margolis Center for Health Policy at Duke University, Director and Robert J. Margolis, MD, Professor of Business, Medicine and Policy |
Session 2: The Value of the Patient Voice
Jennifer Bright | Momentum Health Strategies, President |
Susan dosReis | University of Maryland School of Pharmacy, Professor and Vice Chair for Research, Pharmaceutical Health Services Research |
Lisa Bo Feng | Cystic Fibrosis Foundation, Senior Director of Policy and Advocacy |
Josh Seidman | Avalere Health, Managing Director |
David Steinhorn | Children’s National Medical Center, Division of Critical Care, PANDA Palliative Care Program, Medical Director; George Washington University, Professor of Pediatrics |
Session 3: Keynote Discussion – The Dark Side of Innovation: Biases and Blind Spots
Caterina Bulgarella | Be Thread, Co-Founder and Managing Director |
Session 4: Leveraging Innovation to Drive Value
Adimika Arthur | HealthTech for Medicaid, Executive Director |
Kym Martin | Insperity, Business Performance Advisor |
Sung Hee Choe | Faster Cures, Director |
Jodi G. Daniel | Crowell & Moring, Partner |
Tim Wilson | Quil Health, Chief Financial Officer and Strategy Lead |
Session 5: Future Policy Considerations
Clay Alspach | Leavitt Partners, Principal |
Purva Rawal | CapView Strategies, Principal; Georgetown University, Adjunct Professor |
Experts and Analysts
Edo Banach | National Hospice and Palliative Care Organization, President & CEO |
Deep Banerjee | S&P Global Ratings, Lead Analyst |
Julie Barnes | Maverick Health Policy, Principal and Founder |
Otis Brawley | Johns Hopkins University, Bloomberg Distinguished Professor of Oncology and Epidemiology |
Mandy Cohen | North Carolina Department of Health and Human Services, Secretary |
Russ Dexter | Community Health Center Association of Connecticut, Chief Innovation Officer |
Esther Krofah | Faster Cures, Senior Director |
Rena Conti | Boston University Institute for Health System Innovation and Policy, Associate Research Director of Biopharma and Public Policy |
Paul Cotton | National Committee for Quality Assurance, Director of Federal Affairs |
Sarah Emond | Institute for Clinical and Economic Review, Executive Vice President and COO |
Lisa Fitzpatrick | Grapevine Health, Founder and Chief Executive Officer |
Kate Goodrich | CMS, Director and Chief Medical Officer, Center for Clinical Standards and Quality |
Len Nichols | George Mason University, Director of the Center for Health Policy Research and Ethics |
Carol Regan | Community Catalyst, Senior Advisor for Center for Consumer Engagement in Health |
Lisa Suennen | Manatt Digital and Technology, Group Leader |